On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVE™ (Pneumococcal…
On Apr. 1, 2024, Otsuka Pharmaceutica and Click Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Sept. 28, 2023, Amicus Therapeutics’ treatment for a rare muscle disorder called Pompe disease was approved by…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
On Jun. 3, 2022, BD announced it will introduce new cell sorting technology at the International Society for…
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability of the company’s lab-developed…
On Jun. 30, 2022, BD (Becton, Dickinson) announced that the BD MAX Respiratory Viral Panel (RVP), a new…
On Jun. 23, 2022, Innovation Pharmaceuticals reported that Brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity,…
On Jun. 7, 2022, Zoetis announced an agreement to acquire Basepaws, a privately held petcare genetics company, which…
On Jun. 7, 2022, Merck and Ridgeback Biotherapeutics announced the Annals of Internal Medicine had published additional data…
On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Apr. 27, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service announced it had…
On Apr. 20, 2022, Tonix Pharmaceuticals announced the results of a retrospective observational database study in over 50,000…
On Apr. 14, 2022, Merck announced that V116, the companyﾒs investigational 21-valent pneumococcal conjugate vaccine, had received Breakthrough…
On Apr. 1, 2022, Merck and Ridgeback Biotherapeutics announced data evaluating LAGEVRIO (molnupiravir), an investigational oral antiviral COVID-19…
On Mar. 29, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
On Mar. 17, 2022, Soligenix announced the results of a booster vaccination study using CiVax™ (heat stable COVID-19…
On Jan. 4, 2022, Tonix Pharmaceuticals announced an exclusive option agreement and research collaboration with Kansas State University…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Nov. 22, 2021, Tonix Pharmaceuticals announced the publication of ‘Sangivamycin is highly effective against SARS-CoV-2 in vitro…
On Sept. 28, 2021, Quest Diagnostics reported that one in two (50.5%) American children under six years of…
On Sept. 28, 2021, Soligenix announced publication of pre-clinical immunogenicity studies for CiVax (heat stable COVID-19 vaccine program)…